The anti- @entity934 receptor antibody test in suspected XXXX .

@entity1 @entity1737 @entity892 @entity1736 @entity934
Aim. To estimate the clinical significance of anti- @entity934 receptor antibody (anti-AChR-Ab) levels in suspected @entity1737 . Methods. In total, 144 @entity1 complaining of fluctuating @entity892 and @entity1736 were evaluated for serum levels of anti- @entity934 receptor antibody and their medical charts were retrospectively reviewed. Subjects were classified into three groups: variable @entity892 only, @entity1736 only, and both variable @entity892 and @entity1736 . We investigated serum anti-AChR-Ab titer levels and performed thyroid autoantibody tests. Results. @entity1 ' chief complaints were @entity892 (N = 103), @entity1736 (N = 12), and their concurrence (N = 29). Abnormal anti-AChR-Ab was observed in 21 of 144 @entity1 (14.1%). Between the three groups, mean age, number of seropositive @entity1 , and mean anti-AChR-Ab level were not significantly different (P = 0.224, 0.073, and 0.062, resp.). Overall, 27.5% of @entity1 had abnormal thyroid autoantibodies. Conclusion. The sensitivity of anti-AChR-Ab was 14.1% in suspected @entity1737 and seropositivity in @entity1737 @entity1 showed a high correlation with the presence of thyroid autoantibodies.
